| 18-Jun-13 06:00AM | John Northcott Joins Lexicon as Vice President of Marketing, Commercial Strategy and Operations PR Newswire |
| 12-Jun-13 08:56PM | Lexicon Pharmaceuticals' Management Presents at 38th Annual dbAccess Health Care Conference (Transcript) at Seeking Alpha |
| 11-Jun-13 03:19PM | Lexicon dips as analyst questions diabetes drug AP |
| 09:20AM | Stock Downgrades: Dark Day for Lululemon at Minyanville |
| 07-Jun-13 06:00AM | Lexicon To Present At The Goldman Sachs Global Healthcare Conference PR Newswire |
| 01-Jun-13 03:20PM | Which of These Billion-Dollar Biotechs Is a Buy? at Motley Fool |
| 31-May-13 06:00AM | Lexicon To Present At The Jefferies Global Healthcare Conference PR Newswire |
| 29-May-13 05:46PM | Lexicon Pharmaceuticals' CEO Presents at 38th Annual dbAccess Health Care Conference (Transcript) at Seeking Alpha |
| 28-May-13 06:00AM | Lexicon To Present At The Deutsche Bank dbAccess Healthcare Conference PR Newswire |
| 17-May-13 01:04PM | LEXICON PHARMACEUTICALS, INC./DE Financials EDGAR Online Financials |
| 16-May-13 10:19AM | Lexicon's Management Presents at Bank of America Merrill Lynch 2013 Health Care Conference (Transcript) at Seeking Alpha |
| 13-May-13 06:00AM | Lexicon To Present At The Bank of America Merrill Lynch Healthcare Conference PR Newswire |
| 12-May-13 11:58AM | Lexicon Pharmaceuticals Earnings Call Nuggets: Partnership Talks Update and Carcinoid Enrollment at Wall St. Cheat Sheet |
| 10-May-13 01:26PM | Lexicon Pharmaceuticals' CEO Discusses Q1 2013 Results - Earnings Call Transcript at Seeking Alpha |
| 07:07AM | Q1 2013 Lexicon Pharmaceuticals Inc. Earnings Release - Before Market Open CCBN |
| 06:08AM | Lexicon Pharmaceuticals advances LX4211 in type 1 diabetes Phase 2 trial theflyonthewall.com |
| 06:01AM | Lexicon Advances LX4211 In Type 1 Diabetes Phase 2 Trial PR Newswire |
| 06:00AM | Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2013 First Quarter Financial Results PR Newswire |
| 01:37AM | LEXICON PHARMACEUTICALS, INC./DE Files SEC form 8-K, Results of Operations and Financial Condition, Financial Stateme EDGAR Online |
| 09-May-13 09:26AM | LEXICON PHARMACEUTICALS, INC./DE Files SEC form 8-K, Submission of Matters to a Vote of Security Holders EDGAR Online |
| 03-May-13 06:00AM | Lexicon to Report First Quarter Financial Results on May 10, 2013 PR Newswire |
| 30-Apr-13 03:20PM | No News Becoming Bad News For Lexicon Pharmaceuticals at Seeking Alpha |
| 29-Apr-13 01:07PM | Lexicon Pharma Falls on Concerns Raised by Merck-Pfizer Diabetes Partnership at TheStreet -10.96% |
| 11:28AM | Lexicon Pharma Falls on Concerns Raised by Merck-Pfizer Diabetes Partnership at TheStreet |
| 11:25AM | FDA Loosening Restrictions and Companies More Diligent in Producing Data the FDA Wants: An Expert Analyst Discusses Drivers in the Favorable Regulatory Environment with The Wall Street Transcript Wall Street Transcript |
| 25-Apr-13 06:00AM | Lexicon To Present At The Needham Healthcare Conference PR Newswire +5.05% |
| 24-Apr-13 09:54AM | Why Lexicon Is Poised to Pull Back at Motley Fool |
| 02-Apr-13 03:23PM | 8 Stocks Under $5 Seeing Institutional And Insider Buying at TheStreet |
| 29-Mar-13 03:25PM | U.S. FDA approves Johnson & Johnson diabetes drug, canagliflozin at Reuters |
| 19-Mar-13 02:21PM | 3 Stocks With Insider Interest at Motley Fool |
| 15-Mar-13 01:04PM | LEXICON PHARMACEUTICALS, INC./DE Financials EDGAR Online Financials |
| 11-Mar-13 04:17PM | LEXICON PHARMACEUTICALS, INC./DE Files SEC form 10-K, Annual Report EDGAR Online |
| 01:28PM | 10 Stocks Insiders And Hedge Funds Think Will Go Higher at TheStreet |
| 01-Mar-13 06:00AM | Lexicon To Present At The Cowen Healthcare Conference PR Newswire |
| 25-Feb-13 01:03PM | Investors await news of Lexicon, pharma partnership at bizjournals.com |
| 06:00AM | Lexicon To Present At The RBC Capital Markets Healthcare Conference PR Newswire |
| 23-Feb-13 08:12PM | New Star Analyst Rankings for Lexicon Pharmaceuticals, Inc. StarMine |
| 22-Feb-13 07:26PM | New Star Analyst Rankings for Lexicon Pharmaceuticals, Inc. StarMine |
| 08:20AM | Sharp Increase in FDA Drug Approvals a Major Factor in Biotech Industry's Success Marketwire |
| 21-Feb-13 05:15PM | Lexicon Pharmaceuticals' CEO Discusses Q4 2012 Results - Earnings Call Transcript at Seeking Alpha |
| 08:25AM | LEXICON PHARMACEUTICALS, INC./DE Files SEC form 8-K, Results of Operations and Financial Condition, Financial Stateme EDGAR Online |
| 07:07AM | Q4 2012 Lexicon Pharmaceuticals Inc. Earnings Release - Before Market Open CCBN |
| 06:00AM | Lexicon Pharmaceuticals Provides Clinical Pipeline Update And Reports 2012 Fourth Quarter And Full Year Financial Results PR Newswire |
| 18-Feb-13 06:00AM | Lexicon to Report Fourth Quarter and Year End 2012 Financial Results on February 21, 2013 PR Newswire |
| 06-Feb-13 06:00AM | Lexicon To Present At The BIO CEO & Investor Conference PR Newswire |
| 30-Jan-13 11:43AM | Keryx Defies Gravity at Motley Fool |
| 18-Jan-13 08:20AM | Mergers and Acquisitions Within the Biotech Industry Expected to Rise in 2013 Marketwire |
| 17-Jan-13 01:41PM | Synageva director bought shares for trust at MarketWatch |
| 09-Jan-13 03:26PM | Lexicon Pharmaceuticals' Management Presents at 31st Annual J.P. Morgan Healthcare Conference (Transcript) at Seeking Alpha |
| 03-Jan-13 10:07AM | Why Lexicon Pharmaceuticals Is Poised to Underperform at Motley Fool |
| 08:59AM | Investors Wait On Developments For Lexicon Pharmaceuticals at Seeking Alpha |
| 06:00AM | Lexicon To Present At The J.P. Morgan Healthcare Conference PR Newswire |
| 02-Jan-13 12:03PM | Whoa! What Just Happened to My Stock? at Motley Fool +7.69% |
| 31-Dec-12 05:58PM | J&J Gets FDA Approval for Sirturo, Lexicon Wins Fast Track for LX1033: Healthcare Business Update at Wall St. Cheat Sheet +15.71% |
| 26-Dec-12 09:55AM | Three Compelling Biopharma Stocks For 2013 at Seeking Alpha |
| 20-Dec-12 06:34PM | Could a Virus Make You Lots of Money? at Motley Fool |
| 19-Dec-12 07:07PM | 1 Biotech Off to the Races at Motley Fool |
| 18-Dec-12 10:39AM | Lexicon Pharmaceuticals IBS Drug Gets on FDA Fast Track at Motley Fool |
| 08:59AM | On The Fly: Pre-market Movers theflyonthewall.com |
| 17-Dec-12 02:35PM | Why Lexicon Pharmaceuticals Fast-Tracked Higher at Motley Fool +6.42% |
| 12:10PM | FDA fast-tracks Lexicon Pharmaceuticals' IBS drug at bizjournals.com |
| 09:10AM | On The Fly: Pre-market Movers theflyonthewall.com |
| 08:33AM | Clearwire drops as reality takes hold optionMONSTER |
| 08:31AM | Lexicon drug receives fast track status from FDA AP |
| 08:23AM | 3 Small Pharma Companies With Major Catalysts In 2013 at Seeking Alpha |
| 07:50AM | BRIEF-Lexicon Pharma up in premarket after drug candidate gets fast track status from FDA at Reuters |
| 07:37AM | Morning Movers: Apple, Yen, Weatherford, ClearWire at Bloomberg |
| 06:08AM | InPlay from Briefing.com Briefing.com |
| 06:01AM | InPlay: Lexicon Pharma announced that it has received 'Fast Track' status from the FDA for the development of LX1033 Briefing.com |
| 06:00AM | Lexicon's Drug Candidate For Irritable Bowel Syndrome Receives Fast Track Status From The FDA PR Newswire |
| 15-Dec-12 05:39PM | The Best of 2012 #9: Hemispherx BioPharma at Motley Fool |
| 07-Dec-12 08:20AM | Biotech Industry Skyrockets in 2012 as FDA New Drug Approval Rate Increases Marketwire |
| 05-Dec-12 12:35PM | 3 Things to Watch at Lexicon at Motley Fool |
| 20-Nov-12 06:00AM | Lexicon Pharmaceuticals To Present At The Piper Jaffray Annual Healthcare Conference PR Newswire +5.45% |
| 12-Nov-12 08:32AM | PropThink: Galena: One of Biotech's Most Vulnerable Names Thomson Reuters ONE |
| 06:00AM | Lexicon Pharmaceuticals to Present at the Jefferies 2012 Global Healthcare Conference PR Newswire |
| 10-Nov-12 01:04PM | LEXICON PHARMACEUTICALS, INC./DE Financials EDGAR Online Financials |
| 07-Nov-12 11:28AM | Still Bullish on BioMarin, Lexicon Pharma at TheStreet -5.32% |
| 09:36AM | New Star Analyst Rankings for Lexicon Pharmaceuticals, Inc. StarMine |
| 08:28AM | LEXICON PHARMACEUTICALS, INC./DE Files SEC form 10-Q, Quarterly Report EDGAR Online |
| 07:23AM | Multivitamin Study Results, Vivus Craters On Q3: Healthcare Business Wrap at Wall St. Cheat Sheet |
| 06-Nov-12 08:11PM | Multivitamin Study Results, Vivus Craters On Q3: Healthcare Business Wrap at Wall St. Cheat Sheet |
| 05:56PM | Multivitamin Study Results, Vivus Craters On Q3: Healthcare Business Wrap at Wall St. Cheat Sheet |
| 03:23PM | Lexicon Pharmaceuticals' CEO Discusses Q3 2012 Results - Earnings Call Transcript at Seeking Alpha |
| 10:31AM | InPlay: Lexicon Pharma presents LX4211 Phase 2b results at American Heart Association Annual Conference; primary efficacy endpoint of change from baseline to Week 12 in HbA1c was achieved Briefing.com |
| 10:30AM | LX4211 Phase 2b Results Presented At American Heart Association Annual Conference PR Newswire |
| 08:19AM | LEXICON PHARMACEUTICALS, INC./DE Files SEC form 8-K, Results of Operations and Financial Condition, Financial Stateme EDGAR Online |
| 07:07AM | Q3 2012 Lexicon Pharmaceuticals Inc. Earnings Release - Before Market Open CCBN |
| 06:00AM | Lexicon Pharmaceuticals Reports on Clinical Program Status and 2012 Third Quarter Results PR Newswire |
| 02-Nov-12 07:21PM | 3 Horrendous Healthcare Stocks This Week at Motley Fool -7.35% |
| 31-Oct-12 02:12PM | 5 Stocks Insiders Love Right Now at TheStreet |
| 06:00AM | Lexicon to Provide Third Quarter 2012 Financial Results PR Newswire |
| 29-Oct-12 03:24PM | PropThink: Lexicon's Stock Offering; In Biotech, it's "Raise When You Can" Thomson Reuters ONE |
| 28-Oct-12 07:33AM | Top 5 Stocks With Insider Buys Filed During The Week Ending October 26 at Seeking Alpha |
| 19-Oct-12 12:24PM | LEXICON PHARMACEUTICALS, INC./DE Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements EDGAR Online |
| 18-Oct-12 01:44PM | Attack of the Creeping Share Count at Motley Fool -9.60% |
| 12:16PM | Lexicon Pharmaceuticals prices public offering of 17.5M shares at bizjournals.com |
| 09:27AM | InPlay: Lexicon announces pricing of common stock offering at $2.25/share Briefing.com |
| 09:25AM | Lexicon Announces Pricing Of Common Stock Offering PR Newswire |
| 17-Oct-12 08:51PM | Biotech's Hottest Trend -- Dilution at Motley Fool |
